Compare Amgen, Inc. (AMGN) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Super Micro Computer Inc — how do they compare? Amgen, Inc. trades at $357.16 (market cap $196.12B), while Super Micro Computer Inc trades at $27.96 (market cap $18.31B). The key difference: Amgen, Inc. is far larger — about 10.7× Super Micro Computer Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| AMGN | SMCI | |
|---|---|---|
Market Cap | $196.12B | $18.31B |
Sector | Health | Technology |
52-Week High | $388.16 | $60.71 |
52-Week Low | $271.18 | $20.53 |
Enterprise Value | $241.41B | $25.83B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Super Micro Computer (SMCI) trades at $28.31, up 0.25% with bearish technical signals despite recent earnings beats. The stock faces headwinds from a Taiwan investigation into alleged AI server exports, contributing to a 36% decline in June. Fundamentally, the company shows strong revenue growth with $21.97B in 2025 and improved net income margins, but cash flow trends raise concerns with projected negative operating cash flow in 2026.
The investment outlook is mixed: valuation metrics appear attractive with P/E of 14.9 and P/S of 0.56, and analysts maintain a $36.43 price target. However, significant risks include the ongoing Taiwan probe, working capital pressures, and competitive threats in the AI infrastructure space that could impact future growth and margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
